We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+25.05%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$73.8B
AUM Growth
-$45B
(-38%)
Cap. Flow
-$66.7B
Cap. Flow
% of AUM
-90.35%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
3,841
New
51
Increased
330
Reduced
2,079
Closed
1,309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$184M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$161M |
| 3 |
Royalty Pharma
RPRX
|
+$161M |
| 4 |
SBA Communications
SBAC
|
+$148M |
| 5 |
American Homes 4 Rent
AMH
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.36B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
Amazon
AMZN
|
+$1.14B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$628M |
| 5 |
Meta Platforms (Facebook)
META
|
+$602M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 12.19% |
| 3 | Healthcare | 12.05% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Vicor
VICR
$9.63B
| $669K | ﹤0.01% |
9,296
-1,506
| -14% | -$84.6K |
|
1852
Pacira BioSciences
PCRX
$974M
| $668K | ﹤0.01% |
12,723
-11,095
| -47% | -$464K |
|
|
HBMD
1853
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $666K | ﹤0.01% |
62,700
-56,916
| -48% | -$581K |
|
1854
Schneider National
SNDR
$6.18B
| $661K | ﹤0.01% |
26,775
+13,275
| +98% | +$292K |
|
1855
Kodiak Sciences
KOD
$2.72B
| $659K | ﹤0.01% |
12,184
-4,330
| -26% | -$244K |
|
1856
Movado Group
MOV
$817M
| $659K | ﹤0.01% |
60,752
-31,912
| -34% | -$344K |
|
1857
STAAR Surgical
STAA
$1.25B
| $659K | ﹤0.01% |
10,704
-9,258
| -46% | -$378K |
|
|
LVGO
1858
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $655K | ﹤0.01% |
8,716
-4,914
| -36% | -$257K |
|
1859
Supernus Pharmaceuticals
SUPN
$2.74B
| $653K | ﹤0.01% |
27,494
-23,666
| -46% | -$523K |
|
|
DMC
1860
Del Monte Corp
DMC
$1.43B
| $652K | ﹤0.01% |
26,500
-18,200
| -41% | -$477K |
|
1861
RE/MAX Holdings
RMAX
$243M
| $651K | ﹤0.01% |
20,697
-16,977
| -45% | -$450K |
|
|
TCO
1862
DELISTED
Taubman Centers Inc.
TCO
| $649K | ﹤0.01% |
17,192
-4,024
| -19% | -$164K |
|
1863
Installed Building Products
IBP
$6.27B
| $647K | ﹤0.01% |
9,407
-155,407
| -94% | -$8.61M |
|
1864
Ashland
ASH
$3.45B
| $646K | ﹤0.01% |
9,351
-9,643
| -51% | -$599K |
|
1865
Azenta
AZTA
$1.54B
| $642K | ﹤0.01% |
14,514
-12,604
| -46% | -$482K |
|
|
ATHX
1866
DELISTED
Athersys, Inc. Common Stock
ATHX
| $640K | ﹤0.01% |
+9,278
| New | +$645K |
|
1867
Axsome Therapeutics
AXSM
$11.4B
| $639K | ﹤0.01% |
7,769
-14,651
| -65% | -$1.13M |
|
1868
Papa John's
PZZA
$785M
| $638K | ﹤0.01% |
8,038
+434
| +6% | +$32.3K |
|
1869
Peabody Energy
BTU
$3B
| $637K | ﹤0.01% |
221,233
-352,647
| -61% | -$1.16M |
|
1870
Encore Capital Group
ECPG
$2.01B
| $636K | ﹤0.01% |
18,611
-22,717
| -55% | -$677K |
|
|
PRNB
1871
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $634K | ﹤0.01% |
10,606
-4,312
| -29% | -$266K |
|
1872
Schrodinger
SDGR
$1.4B
| $633K | ﹤0.01% |
6,915
-7,001
| -50% | -$408K |
|
|
ALLK
1873
DELISTED
Allakos
ALLK
| $627K | ﹤0.01% |
8,727
-165,233
| -95% | -$11.1M |
|
1874
SPS Commerce
SPSC
$2.69B
| $626K | ﹤0.01% |
8,339
-6,943
| -45% | -$423K |
|
1875
Vishay Precision Group
VPG
$864M
| $626K | ﹤0.01% |
25,453
+21,383
| +525% | +$481K |
|
Similar funds
VGA
Victory Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Victory Capital Management held 3,841 positions worth $73.8B, down 38% from $119B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Victory Capital Management withdrew a net $66.7B in Q2 2020, closing 1,309 positions and reducing 2,079 holdings. Its most notable exit was AMES National, an estimated $91.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Victory Capital Management opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $170M.
- Victory Capital Management's largest Q2 2020 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,558,761 shares worth $170M.
- Victory Capital Management added most to Tyson Foods in Q2 2020, an estimated $184M increase.
- Victory Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.36B.
- Victory Capital Management fully exited AMES National in Q2 2020, selling an estimated $91.4M.
- Victory Capital Management's ten largest holdings make up 9.4% of its $73.8B portfolio in Q2 2020.
- Victory Capital Management opened 51 new positions and closed 1,309 in Q2 2020.
- Victory Capital Management's portfolio value fell 38% quarter-over-quarter to $73.8B.
Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.